表紙
市場調査レポート

足白癬(水虫)治療薬:パイプライン評価と市場予測(〜2019年)

Athlete's Foot Therapeutics - Pipeline Assessment and Market Forecasts to 2019

発行 GlobalData 商品コード 232364
出版日 ページ情報 英文 59 Pages
即納可能
価格
本日の銀行送金レート: 1USD=101.16円で換算しております。
Back to Top
足白癬(水虫)治療薬:パイプライン評価と市場予測(〜2019年) Athlete's Foot Therapeutics - Pipeline Assessment and Market Forecasts to 2019
出版日: 2012年02月20日 ページ情報: 英文 59 Pages
概要

当レポートでは、世界の足白癬(水虫)治療薬市場について調査分析し、主要7市場の収益実績と予測(2006年〜2019年)、パイプライン分析、現在および将来の競合分析、業界の促進要因・抑制要因と課題、主なトピック(競合企業の評価、市場の特徴、アンメットニーズなど)を提供し、ライセンスや提携契約などの情報も含め、概略以下の構成でお届けいたします。

第1章 目次

第2章 イントロダクション

  • 疾患の概要
  • 疫学
  • 病因
  • 病態
  • 兆候と症状
  • 診断
  • 治療と管理オプション
  • ガイダンス

第3章 市場の特徴

  • 市場規模の実績値・予測値:全世界(2006〜2019年)
  • 市場規模の実績値・予測値:米国(2006〜2019年)
  • 市場規模の実績値・予測値:フランス(2006〜2019年)
  • 市場規模の実績値・予測値:ドイツ(2006〜2019年)
  • 市場規模の実績値・予測値:イタリア(2006〜2019年)
  • 市場規模の実績値・予測値:スペイン(2006〜2019年)
  • 市場規模の実績値・予測値:英国(2006〜2019年)
  • 市場規模の実績値・予測値:日本(2006〜2019年)
  • 市場の促進要因・阻害要因
  • 市場の機会とアンメットニーズ分析
  • 主な結論

第4章 競合評価

  • 概要
  • 戦略的競合企業の評価
  • 主な市販製品クラスの製品プロファイル
  • 主な結論

第5章 パイプライン評価

  • 概要
  • 戦略的パイプライン評価
  • 治験の開発段階(フェーズ)別パイプライン分析
    • フェーズIIIパイプライン
    • フェーズIIパイプライン
    • フェーズIパイプライン
    • 治験前パイプライン
    • 技術動向分析のフレームワーク
  • 作用機序別の臨床パイプライン
  • 治験段階にある有望な薬剤
  • 治験段階にある有望な薬剤の分子プロファイル
    • Nitric Oxide
  • 主な結論

第6章 治験マッピング

  • 地域/国別の治験数(米国・EU5ヶ国・日本)
  • フェーズ別の治験数
  • 進捗状況別の治験数
  • 有望なスポンサー
  • スポンサー別の治験数
  • 治験に参加している上位企業

第7章 戦略的評価

  • 将来の市場に影響を与える出来事
  • 将来の市場競合への影響

第8章 将来の参入企業

  • イントロダクション
  • 企業プロファイル
    • Quinnova Pharmaceuticals, Inc.
    • Nitric Biotherapeutics, Inc.
    • Anacor Pharmaceuticals, Inc.
    • その他の企業

第9章 ライセンスと提携取引

第10章 付録

図表

目次

Summary

GlobalData, the industry analysis specialist, has released its new report, "Athlete's Foot Therapeutics - Pipeline Assessment and Market Forecasts to 2019". The report is an essential source of information and analysis on the global Athlete's Foot Therapeutics market. The report identifies the key trends shaping and driving the global Athlete's Foot Therapeutics market. The report also provides insights on the prevalent competitive landscape and the emerging players expected to significantly alter the market positioning of the current market leaders. Most importantly, the report provides valuable insights on the pipeline products within the global Athlete's Foot Therapeutics sector. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Scope

The report provides information on the key drivers and challenges of the Athlete's Foot Therapeutics market. Its scope includes -

  • Annualized seven key markets (US, France, Germany, Italy, Spain, UK and Japan) Athlete's Foot Therapeutics market revenues data from 2006 to 2011, forecast for eight years to 2019.
  • Pipeline analysis data providing a split across the different phases, mechanisms of action being developed and emerging trends by seven key markets. Pipeline candidates fall under major therapeutic classes.
  • Analysis of the current and future competition in the seven key countries Athlete's Foot Therapeutics market.
  • Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide a qualitative analysis of its implications.
  • Key topics covered include strategic competitor assessment, market characterization, unmet needs and the implications for the Athlete's Foot Therapeutics market.
  • Analysis of key recent licensing and partnership agreements in Athlete's Foot Therapeutics market

Reasons to buy

The report will enhance your decision making capability. It will allow you to -

  • Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies and by identifying the companies with the most robust pipeline.
  • Develop business strategies by understanding the trends shaping and driving the global Athlete's Foot Therapeutics market.
  • Drive revenues by understanding the key trends, innovative products and technologies, market segments and companies likely to impact the global Athlete's Foot Therapeutics market in future.
  • Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
  • Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
  • Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.
  • What's the next big thing in the global Athlete's Foot Therapeutics market landscape? - Identify, understand and capitalize.

Table of contents

1. Table of Contents

  • 1.1. List of Tables
  • 1.2. List of Figures

2. Athlete's Foot Therapeutics - Introduction

  • 2.1. Disease Overview
  • 2.2. Epidemiology
  • 2.3. Etiology
  • 2.4. Pathophysiology
  • 2.5. Signs and Symptoms
  • 2.6. Diagnosis
  • 2.7. Treatment and Management Options
  • 2.8. GlobalData Pipeline Report Guidance

3. Athlete's Foot Therapeutics - Market Characterization

  • 3.1. Athlete's Foot Therapeutics Market Size (2006-2011) - Global
  • 3.2. Athlete's Foot Therapeutics Market Forecast (2011-2019) - Global
  • 3.3. Athlete's Foot Therapeutics Market Size (2006-2011) - The US
  • 3.4. Athlete's Foot Therapeutics Market Forecast (2011-2019) - The US
  • 3.5. Athlete's Foot Therapeutics Market Size (2006-2011) - France
  • 3.6. Athlete's Foot Therapeutics Market Forecast (2011-2019) - France
  • 3.7. Athlete's Foot Therapeutics Market Size (2006-2011) - Germany
  • 3.8. Athlete's Foot Therapeutics Market Forecast (2011-2019) - Germany
  • 3.9. Athlete's Foot Therapeutics Market Size (2006-2011) - Italy
  • 3.10. Athlete's Foot Therapeutics Market Forecast (2011-2019) - Italy
  • 3.11. Athlete's foot Therapeutics Market Size (2006-2011) - Spain
  • 3.12. Athlete's Foot Therapeutics Market Forecast (2011-2019) - Spain
  • 3.13. Athlete's Foot Therapeutics Market Size (2006-2011) - The UK
  • 3.14. Athlete's Foot Therapeutics Market Forecast (2011-2019) - The UK
  • 3.15. Athlete's Foot Therapeutics Market Size (2006-2011) - Japan
  • 3.16. Athlete's Foot Therapeutics Market Forecast (2011-2019) - Japan
  • 3.17. Drivers and Barriers for the Athlete's Foot Therapeutics Market
    • 3.17.1. Drivers for the Athlete's Foot Therapeutics Market
    • 3.17.2. Barriers for the Athlete's Foot Therapeutics Market
  • 3.18. Opportunity and Unmet Need Analysis
  • 3.19. Key Takeaway

4. Athlete's Foot Therapeutics - Competitive Assessment

  • 4.1. Overview
  • 4.2. Strategic Competitor Assessment
  • 4.3. Product Profiles for the Major Marketed Product Classes in the Athlete's Foot Therapeutics Market
  • 4.4. Key Takeaway

5. Athlete's Foot Therapeutics - Pipeline Assessment

  • 5.1. Overview
  • 5.2. Strategic Pipeline Assessment
  • 5.3. Athlete's Foot Therapeutics Pipeline - Pipeline by Phases of Development
    • 5.3.1. Athlete's Foot Therapeutics - Phase III Pipeline
    • 5.3.2. Athlete's Foot Therapeutics - Phase II Pipeline
    • 5.3.3. Athlete's Foot Therapeutics - Phase I Pipeline
    • 5.3.4. Athlete's Foot Therapeutics - Pre-Clinical Pipeline
    • 5.3.5. Technology Trends Analytic Framework
  • 5.4. Athlete's Foot Therapeutics Market - Clinical Pipeline by Mechanism of Action
  • 5.5. Athlete's Foot Therapeutics - Promising Drugs Under Clinical Development
  • 5.6. Molecule Profiles for Promising Drugs in Clinical Development
    • 5.6.1. Nitric Oxide
  • 5.7. Key Takeaway

6. Athlete's Foot Therapeutics - Clinical Trials Mapping

  • 6.1. Clinical Trials by Region/Country (The US, EU5 and Japan)
  • 6.2. Clinical Trials by Phase
  • 6.3. Clinical Trials by Trial Status
  • 6.4. Prominent Sponsors
  • 6.5. Clinical Trials by Overall Sponsors
  • 6.6. Top Companies Participating in Athlete's Foot Therapeutics Clinical Trials

7. Athlete's Foot Therapeutics - Strategic Assessment

  • 7.1. Key Events Impacting the Future Market
  • 7.2. Athlete's Foot Therapeutics: Implications for Future Market Competition

8. Athlete's Foot Therapeutics - Future Companies

  • 8.1. Introduction
  • 8.2. Company Profiles
    • 8.2.1. Quinnova Pharmaceuticals, Inc.
    • 8.2.2. Nitric Biotherapeutics, Inc.
    • 8.2.3. Anacor Pharmaceuticals, Inc.
    • 8.2.4. Other Companies in Market

9. Athlete's Foot Therapeutics - Licensing and Partnership Deals

10. Athlete's Foot Therapeutics - Appendix

  • 10.1. Market Definitions
  • 10.2. Abbreviations
  • 10.3. Methodology
    • 10.3.1. Coverage
    • 10.3.2. Secondary Research
    • 10.3.3. Forecasting
    • 10.3.4. Primary Research
    • 10.3.5. Expert Panel Validation
  • 10.4. Contact Us
  • 10.5. Disclaimer
  • 10.6. Bibliography

List of Tables

  • Table 1: Prevalence of Athlete's Foot in the US, EU5 and Japan
  • Table 2: Athlete's Foot Therapeutics Market, Global, Revenue ($m), 2006-2011
  • Table 3: Athlete's Foot Therapeutics Market, Global, Forecast ($m), 2011-2019
  • Table 4: Athlete's Foot Therapeutics Market, The US, Revenue ($m), 2006-2011
  • Table 5: Athlete's Foot Therapeutics Market, The US, Forecast ($m), 2011-2019
  • Table 6: Athlete's Foot Therapeutics Market, France, Revenue ($m), 2006-2011
  • Table 7: Athlete's Foot Therapeutics Market, France, Forecast ($m), 2011-2019
  • Table 8: Athlete's Foot Therapeutics Market, Germany, Revenue ($m), 2006-2011
  • Table 9: Athlete's Foot Therapeutics Market, Germany, Forecast ($m), 2011-2019
  • Table 10: Athlete's Foot Therapeutics Market, Italy, Revenue ($m), 2006-2011
  • Table 11: Athlete's Foot Therapeutics Market, Italy, Forecast ($m), 2011-2019
  • Table 12: Athlete's Foot Therapeutics Market, Spain, Revenue ($m), 2006-2011
  • Table 13: Athlete's Foot Therapeutics Market, Spain, Forecast ($m), 2011-2019
  • Table 14: Athlete's Foot Therapeutics Market, The UK, Revenue ($m), 2006-2011
  • Table 15: Athlete's Foot Therapeutics Market, The UK, Forecast ($m), 2011-2019
  • Table 16: Athlete's Foot Therapeutics Market, Japan, Revenue ($m), 2006-2011
  • Table 17: Athlete's Foot Therapeutics Market, Japan, Forecast ($m), 2011-2019
  • Table 18: Athlete's Foot Therapeutics - Phase II Pipeline, as of November,2011
  • Table 19: Athlete's Foot Therapeutics - Phase II Pipeline, 2011
  • Table 20: Athlete's Foot Therapeutics - Phase I Pipeline, 2011
  • Table 21: Athlete's Foot Therapeutics - Pre-Clinical Pipeline, 2011
  • Table 22: Athlete's Foot Therapeutics -Promising Drugs Under Clinical Development, 2011
  • Table 23: Athlete's Foot Therapeutics Market - Clinical Trials by Region/Country, 2011
  • Table 24: Athlete's Foot Therapeutics - Clinical Trials by Phase, 2011
  • Table 25: Athlete's Foot Therapeutics - Clinical Trials by Status, 2011
  • Table 26: Athlete's Foot Therapeutics -Prominent Sponsors, 2011
  • Table 27: Athlete's Foot Therapeutics - Overall Sponsors, 2011
  • Table 28: Athlete's Foot Therapeutics - Top Companies Participating in Therapeutics Clinical Trials, 2011
  • Table 29: Quinnova Pharmaceuticals, Inc. Infectious Disease Pipeline, 2011
  • Table 30: Nitric Biotherapeutics, Inc. - Infectious Disease Pipeline Products, 2011
  • Table 31: Anacor Pharmaceuticals - Infectious Disease Pipeline, 2011
  • Table 32: Athlete's Foot Therapeutics Market - Future Companies
  • Table 33: Athlete's Foot Therapeutics, Global, Deals

List of Figures

  • Figure 1: Athlete's Foot
  • Figure 2: Athlete's Foot Therapeutics Market, Global, Revenue ($m), 2006-2011
  • Figure 3: Athlete's Foot Therapeutics Market, Global, Forecast ($m), 2011-2019
  • Figure 4: Athlete's Foot Therapeutics Market, The US, Revenue ($m), 2006-2011
  • Figure 5: Athlete's Foot Therapeutics Market, The US, Forecast ($m), 2011-2019
  • Figure 6: Athlete's Foot Therapeutics Market, France, Revenue ($m), 2006-2011
  • Figure 7: Athlete's Foot Therapeutics Market, France, Forecast ($m), 2011-2019
  • Figure 8: Athlete's Foot Therapeutics Market, Germany, Revenue ($m), 2006-2011
  • Figure 9: Athlete's Foot Therapeutics Market, Germany, Forecast ($m), 2011-2019
  • Figure 10: Athlete's Foot Therapeutics Market, Italy, Revenue ($m), 2006-2011
  • Figure 11: Athlete's Foot Therapeutics Market, Italy, Forecast ($m), 2011-2019
  • Figure 12: Athlete's Foot Therapeutics Market, Spain, Revenue ($m), 2006-2011
  • Figure 13: Athlete's Foot Therapeutics Market, Spain, Forecast ($m), 2011-2019
  • Figure 14: Athlete's Foot Therapeutics Market, The UK, Revenue ($m), 2006-2011
  • Figure 15: Athlete's Foot Therapeutics Market, The UK, Forecast ($m), 2011-2019
  • Figure 16: Athlete's Foot Therapeutics Market, Japan, Revenue ($m), 2006-2011
  • Figure 17: Athlete's Foot Therapeutics Market, Japan, Forecast ($m), 2011-2019
  • Figure 18: Opportunity and Unmet Need in the Athlete's Foot Therapeutics Market, 2011
  • Figure 19: Athlete's Foot Therapeutics - Strategic Competitor Assessment, 2011
  • Figure 20: Athlete's Foot Therapeutics - Pipeline by Phase of Development, 2011
  • Figure 21: Athlete's Foot Therapeutics - Technology Trends Analytics Framework, 2011
  • Figure 22: Athlete's Foot Therapeutics - Technology Trends Analytics Framework - Description, 2011
  • Figure 23: Athlete's Foot Therapeutics - Pipeline by Mechanism of Action, 2011
  • Figure 24: Athlete's Foot Therapeutics - Clinical Trials by Country, 2011
  • Figure 25: Athlete's Foot Therapeutics - Clinical Trials by Phase, 2011
  • Figure 26: Athlete's Foot Therapeutics - Clinical Trials by Status, 2011
  • Figure 27: Athlete's Foot Therapeutics - Prominent Sponsors, 2011
  • Figure 28: Athlete's Foot Therapeutics - Overall Sponsors, 2011
  • Figure 29: Athlete's Foot Therapeutics - Top Companies Participating in Therapeutics Clinical Trials, 2011
  • Figure 30: Athlete's Foot Therapeutics Market - Drivers and Barriers, 2011
  • Figure 31: Implications for Future Market Competition in the Athlete's Foot Market, 2011
  • Figure 32: Athlete's Foot Therapeutics Market - Pipeline by Company, 2011
  • Figure 33: GlobalData Market Forecasting Model
Back to Top